Literature DB >> 6945824

Haemoglobin and prognosis in childhood acute lymphoblastic leukaemia.

I M Hann, J H Scarffe, M K Palmer, D I Evans, P H Jones.   

Abstract

Two hundred and nine children presenting consecutively with acute lymphoblastic leukaemia to a regional paediatric oncology unit were investigated to determine the prognostic significance of various factors at diagnosis. There was a strong positive correlation between the pretreatment haemoglobin level and the percentage of bone marrow blast cells in S phase of the cell cycle as assessed by flow cytometry. Patients with T- and B-cell leukaemia had significantly higher haemoglobin levels than non-B non-T patients. In patients with total white cell counts less than 20 X 10(9)/l, aged less than 13 years, and no mediastinal mass, there was no association of haemoglobin with length of first remission. However, among those with white blood counts greater than 20 +/- 10(9)/l there was a strong positive trend towards shorter remission with higher haemoglobin levels. Children with high white blood counts at diagnosis and low haemoglobin levels may have a better prognosis than predicted by the white blood count alone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945824      PMCID: PMC1627299          DOI: 10.1136/adc.56.9.684

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Factors influencing survival in pediatric acute leukemia. The SWCCSG experience, 1958-1970.

Authors:  S L George; D J Fernbach; T J Vietti; M P Sullivan; D M Lane; M E Haggard; D H Berry; D Lonsdale; D Komp
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

2.  Prognosis in acute leukaemia of adults.

Authors:  F W Gunz; E W Burns
Journal:  N Z Med J       Date:  1965-10

3.  Interrupted vs. continued maintenance therapy in childhood acute leukemia.

Authors:  D Lonsdale; E A Gehan; D J Fernbach; M P Sullivan; D M Lane; A H Ragab
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

4.  The prognostic significance of morphological features in childhood acute lymphoblastic leukaemia.

Authors:  I M Hann; D I Evans; M K Palmer; P J Morris-Jones; C Haworth
Journal:  Clin Lab Haematol       Date:  1979

5.  Bone-marrow relapse in acute lymphoblastic leukaemia in childhood.

Authors:  M A Cornbleet; J M Chessells
Journal:  Br Med J       Date:  1978-07-08

6.  Time trends in survival in acute lymphocytic leukemia.

Authors:  C Zippin; S J Cutler; D Lum
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

7.  Low IgG or IgA: a further indicator of poor prognosis in childhood acute lymphoblastic leukaemia.

Authors:  I M Hann; P H Jones; D I Evans; G M Addison; M K Palmer; J H Scarffe
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

8.  A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia.

Authors:  M K Palmer; I M Hann; P M Jones; D I Evans
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

9.  Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood.

Authors:  J H Scarffe; I M Hann; D I Evans; P Morris Jones; M K Palmer; J S Lilleyman; D Crowther
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  1 in total

1.  Revisiting the complete blood count and clinical findings at diagnosis of childhood acute lymphoblastic leukemia: 10-year experience at a single center.

Authors:  José Carlos Jaime-Pérez; Gisela García-Arellano; José Luis Herrera-Garza; Luis Javier Marfil-Rivera; David Gómez-Almaguer
Journal:  Hematol Transfus Cell Ther       Date:  2018-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.